Tokyo: Belgium-based Contract Research Organization (CRO) and services provider genae has incorporated 'genae Japan' in Tokyo.

Bart Segers, genae's CEO believes that the incorporation of genae Japan, with its headquarters in Tokyo, will boost their commitment and ability to provide high quality research services on a global scale. The company intends to serve the Greater Tokyo Area, as it is a vast economic region that supports a population of 36 million people.

genae is involved in the development and commercialization of medical devices, biologics and therapies that change medical practice. As a full service CRO and services provider for the medical industries, genae aims at improving health and quality of life by innovating and accelerating high quality research. genae's Quality Management System is ISO 9001 compliant, has been tested rigorously and continues to pass regulatory and sponsor's audits and inspections.